Advertisement
Document › Details
Phenomenex, Inc.. (3/14/17). "Press Release: New Family of Zebron GC Columns for Fast Highly Selective FAME Analysis". Torrance, CA.
Organisation | Phenomenex Inc. | |
Group | Danaher (Group) | |
Product | Zebron™ ZB-FAME GC column | |
Product 2 | gas chromatography (GC) | |
Person | Parnell, Kristen (Phenomenex 201305 Brand Manager for GC Products) | |
Phenomenex Inc., a global leader in the research, design and manufacture of advanced technologies for the separation sciences, introduces a trio of Zebron™ GC columns specially developed for the analysis of fatty acid methyl esters (FAME) in food. Identification and measurement of these compounds in food products such as cheese, peanut butter, infant formula, cooking oils and oil-based nutritional supplements is increasingly important in meeting labeling requirements and testing for product adulteration.
The Zebron ZB-FAME leads the new trio of Phenomenex GC columns. This stationary phase offers selectivity targeting a 37-compound mix, in a column that’s much shorter than traditional solutions. The shorter column reduces run times to about 11 minutes – a decrease of 75 percent or more – while still providing Rs values of 1.0 or greater. Its optimized high-cyanopropyl chemistry delivers the required high polarity for the separation of cis/trans FAME isomers and meets the guidelines of AOAC, AOCS and IOC methods. Zebron ZB-FAME columns also come with a guarantee based on Phenomenex’ unique QC testing protocols, where every column is individually QC-tested against the target 37 compounds for FAME analysis.
"Cis/trans FAME analysis has historically been carried out with long columns, which produce corresponding long run times," explained Kristen Parnell, product marketing manager for Phenomenex. "With our innovative new chemistry, we've been able to improve the separations to such a degree that they can be carried out on far shorter columns, saving analysts up to 45 minutes per run."" The new chemistry is stable enough to withstand temperatures as high as 280 °C, enabling inclusion of column baking steps to remove contaminants traditionally left behind when analyzing food samples, improving column lifetime.
Second in the new trio is Zebron ZB-88 – a new GC alternative to other 88-phase columns for the separation of cis/trans isomers. This column is well suited for the analysis of olive and hydrogenated oils. The third new column, Zebron ZB-23, is a cost-effective alternative to existing 23-phase columns for the separation of cis/trans isomers in a group of products that includes omega-3 and fish oils. Both the ZB-88 and ZB-23 columns can be used in direct substitution for traditional products recommended for use with regulatory methods.
"These three new columns for FAME analysis add to the portfolio we already have in place for food testing," said Parnell. "Our focus is on keeping our ears to the ground in this dynamic industry, listening to the evolving needs of customers and developing innovative solutions to meet them."
For more information regarding this article please contact:
Phenomenex Press Room
Tel: 310-212-0555
Email: pressroom@phenomenex.com
Record changed: 2023-06-05 |
Advertisement
More documents for Danaher (Group)
- [1] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
- [2] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
- [3] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
- [4] Refeyn Ltd.. (1/23/23). "Press Release: Refeyn Appoints Interim CEO"....
- [5] Molecular Devices, LLC. (1/4/23). "Press Release: Molecular Devices and Advanced Solutions Life Sciences Collaborate to Develop 3D Biology Automation Technologies for Drug Discovery". San José, CA....
- [6] Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff....
- [7] Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition"....
- [8] Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin....
- [9] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
- [10] AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows"....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top